ARTG 407188Xenios console for extracorporeal circulation - Cardiopulmonary bypass system centrifugal pump drive unit
ARTG ID: 407188 · Fresenius Medical Care Australia Pty Ltd · Xenios AG · Class IIb · Started March 31, 2023
Good Name: Fresenius Medical Care Australia Pty Ltd - Xenios console for extracorporeal circulation - Cardiopulmonary bypass system centrifugal pump drive unit
- Risk Class
- Class IIb
- Product Type
- Medical device system
- ARTG Category
- General
- ARTG ID
- 407188
- Start Date
- March 31, 2023
- Effective Date
- March 31, 2023
- Name
- Xenios AG
- Country
- Germany
- Address
- Im Zukunftspark 1, Heilbronn, 74076
The Xenios console is intended for use in temporary extracorporeal cardiovascular and cardiopulmonary support for patient stabilisation or therapy.
Access comprehensive regulatory information for Xenios console for extracorporeal circulation - Cardiopulmonary bypass system centrifugal pump drive unit in the Australia medical device market through Pure Global AI's free TGA ARTG database. This Class IIb is registered under ARTG number 407188 and sponsored by Fresenius Medical Care Australia Pty Ltd, manufactured by Xenios AG in Germany. The device registration started on March 31, 2023.
This page provides complete registration details including sponsor information, manufacturer details, and regulatory compliance data from the official Australia TGA ARTG medical device database. Pure Global AI offers free access to Australia's complete medical device registry with 131,000+ devices, helping global MedTech companies navigate TGA regulations efficiently.